Genmab | GEN - EPS - Lucro por Ação

Preço das Ações
1,684.00
Mudança Diária
-28.50 -1.66%
Mensal
-8.63%
Anual
29.99%
Q2 Previsão
1,563.36

Fiscal Calendário Atual Consenso Anterior Data
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Alterar Data
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Almirall EUR 0.07 0.03 2025-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.15 0.14 2026-03
argenx SE USD 4.7 2.1 2026-03
AstraZeneca USD 2.58 0.46 2026-03
Bayer EUR 2.71 2.09 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Demant DKK 6.1 0.5 2025-12
Exelixis USD 0.87 0.1 2026-03
Fresenius Medical Care EUR 0.91 0.53 2026-03
Genmab DKK 3.69 2.77 2025-12
GlaxoSmithKline GBP 0.43 0.17 2026-03
GN Store Nord DKK -2.65 5.16 2026-03
GRIFOLS EUR 0.14 0.11 2026-03
Hikma Pharmaceutical USD 0.65 0.12 2025-12
Insmed USD -0.76 0.78 2026-03
Lakefront Biotherapeutics EUR -0.84 12.73 2026-03
Lonza CHF 6.07 1.92 2025-06
Merck EUR 2.11 0.23 2026-03
Novartis USD 1.99 0.04 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.88 0.35 2026-03
UCB EUR 5.65 3.21 2025-12